nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—Lisinopril—dilated cardiomyopathy	0.362	1	CrCtD
Cilazapril—ACE—dilated cardiomyopathy	0.158	1	CbGaD
Cilazapril—ACE—Lisinopril—dilated cardiomyopathy	0.122	0.63	CbGbCtD
Cilazapril—SLC15A1—Lisinopril—dilated cardiomyopathy	0.0488	0.253	CbGbCtD
Cilazapril—Fosinopril—Lisinopril—dilated cardiomyopathy	0.0418	0.173	CrCrCtD
Cilazapril—Moexipril—Lisinopril—dilated cardiomyopathy	0.0314	0.13	CrCrCtD
Cilazapril—Spirapril—Lisinopril—dilated cardiomyopathy	0.0271	0.112	CrCrCtD
Cilazapril—Ramipril—Lisinopril—dilated cardiomyopathy	0.0255	0.105	CrCrCtD
Cilazapril—Enalapril—Lisinopril—dilated cardiomyopathy	0.0255	0.105	CrCrCtD
Cilazapril—Trandolapril—Lisinopril—dilated cardiomyopathy	0.0255	0.105	CrCrCtD
Cilazapril—Nateglinide—Lisinopril—dilated cardiomyopathy	0.0227	0.094	CrCrCtD
Cilazapril—Quinapril—Lisinopril—dilated cardiomyopathy	0.0216	0.0893	CrCrCtD
Cilazapril—Benazepril—Lisinopril—dilated cardiomyopathy	0.0205	0.0851	CrCrCtD
Cilazapril—ABCB1—Lisinopril—dilated cardiomyopathy	0.012	0.0621	CbGbCtD
Cilazapril—ABCB1—Spironolactone—dilated cardiomyopathy	0.0105	0.0546	CbGbCtD
Cilazapril—ACE—pulmonary artery—dilated cardiomyopathy	0.00215	0.358	CbGeAlD
Cilazapril—ACE—sympathetic nervous system—dilated cardiomyopathy	0.00209	0.348	CbGeAlD
Cilazapril—ACE—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00151	0.265	CbGpPWpGaD
Cilazapril—Dry cough—Lisinopril—dilated cardiomyopathy	0.00143	0.045	CcSEcCtD
Cilazapril—ACE—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.00117	0.206	CbGpPWpGaD
Cilazapril—Pemphigus—Lisinopril—dilated cardiomyopathy	0.00115	0.0363	CcSEcCtD
Cilazapril—Uremia—Lisinopril—dilated cardiomyopathy	0.000876	0.0276	CcSEcCtD
Cilazapril—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.000708	0.0223	CcSEcCtD
Cilazapril—ACE—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.000632	0.111	CbGpPWpGaD
Cilazapril—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.000533	0.0168	CcSEcCtD
Cilazapril—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.000498	0.0157	CcSEcCtD
Cilazapril—ACE—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.000486	0.0855	CbGpPWpGaD
Cilazapril—ACE—cardiac ventricle—dilated cardiomyopathy	0.000446	0.0744	CbGeAlD
Cilazapril—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.000426	0.0134	CcSEcCtD
Cilazapril—Renal pain—Lisinopril—dilated cardiomyopathy	0.000421	0.0132	CcSEcCtD
Cilazapril—ACE—myocardium—dilated cardiomyopathy	0.00042	0.07	CbGeAlD
Cilazapril—Azotaemia—Lisinopril—dilated cardiomyopathy	0.000415	0.0131	CcSEcCtD
Cilazapril—Ataxia—Spironolactone—dilated cardiomyopathy	0.00037	0.0116	CcSEcCtD
Cilazapril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—dilated cardiomyopathy	0.000359	0.0632	CbGpPWpGaD
Cilazapril—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000354	0.0112	CcSEcCtD
Cilazapril—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.000345	0.0109	CcSEcCtD
Cilazapril—ACE—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000342	0.0602	CbGpPWpGaD
Cilazapril—Gout—Furosemide—dilated cardiomyopathy	0.000316	0.00994	CcSEcCtD
Cilazapril—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000313	0.00986	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000301	0.00946	CcSEcCtD
Cilazapril—Renal failure—Spironolactone—dilated cardiomyopathy	0.000298	0.00938	CcSEcCtD
Cilazapril—ACE—heart—dilated cardiomyopathy	0.000293	0.0488	CbGeAlD
Cilazapril—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000283	0.00891	CcSEcCtD
Cilazapril—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000271	0.00853	CcSEcCtD
Cilazapril—Urine output increased—Furosemide—dilated cardiomyopathy	0.000267	0.00839	CcSEcCtD
Cilazapril—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000257	0.0081	CcSEcCtD
Cilazapril—SLC15A2—heart—dilated cardiomyopathy	0.000256	0.0426	CbGeAlD
Cilazapril—Proteinuria—Lisinopril—dilated cardiomyopathy	0.000252	0.00793	CcSEcCtD
Cilazapril—ACE—cardiac atrium—dilated cardiomyopathy	0.000251	0.0418	CbGeAlD
Cilazapril—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000248	0.00782	CcSEcCtD
Cilazapril—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000244	0.00768	CcSEcCtD
Cilazapril—Polyuria—Furosemide—dilated cardiomyopathy	0.000244	0.00768	CcSEcCtD
Cilazapril—Alopecia—Spironolactone—dilated cardiomyopathy	0.000241	0.00757	CcSEcCtD
Cilazapril—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000239	0.00753	CcSEcCtD
Cilazapril—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000237	0.00747	CcSEcCtD
Cilazapril—Gout—Lisinopril—dilated cardiomyopathy	0.000237	0.00746	CcSEcCtD
Cilazapril—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000228	0.00717	CcSEcCtD
Cilazapril—Fosinopril—ACE—dilated cardiomyopathy	0.000224	0.136	CrCbGaD
Cilazapril—Purpura—Furosemide—dilated cardiomyopathy	0.000222	0.00699	CcSEcCtD
Cilazapril—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00022	0.00692	CcSEcCtD
Cilazapril—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000217	0.00684	CcSEcCtD
Cilazapril—Malaise—Spironolactone—dilated cardiomyopathy	0.000214	0.00673	CcSEcCtD
Cilazapril—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000212	0.00668	CcSEcCtD
Cilazapril—Photophobia—Lisinopril—dilated cardiomyopathy	0.000208	0.00654	CcSEcCtD
Cilazapril—Discomfort—Spironolactone—dilated cardiomyopathy	0.000199	0.00628	CcSEcCtD
Cilazapril—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000196	0.00616	CcSEcCtD
Cilazapril—Confusional state—Spironolactone—dilated cardiomyopathy	0.000195	0.00614	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000193	0.00607	CcSEcCtD
Cilazapril—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000189	0.00596	CcSEcCtD
Cilazapril—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000184	0.00579	CcSEcCtD
Cilazapril—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000183	0.00576	CcSEcCtD
Cilazapril—Perindopril—ACE—dilated cardiomyopathy	0.000182	0.111	CrCbGaD
Cilazapril—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000181	0.00571	CcSEcCtD
Cilazapril—Spirapril—ACE—dilated cardiomyopathy	0.00018	0.109	CrCbGaD
Cilazapril—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000178	0.0056	CcSEcCtD
Cilazapril—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000174	0.00548	CcSEcCtD
Cilazapril—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000173	0.00545	CcSEcCtD
Cilazapril—Moexipril—ACE—dilated cardiomyopathy	0.000173	0.105	CrCbGaD
Cilazapril—Somnolence—Spironolactone—dilated cardiomyopathy	0.000172	0.00541	CcSEcCtD
Cilazapril—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000171	0.00538	CcSEcCtD
Cilazapril—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000169	0.00534	CcSEcCtD
Cilazapril—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000169	0.00532	CcSEcCtD
Cilazapril—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000169	0.00531	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000167	0.00526	CcSEcCtD
Cilazapril—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000167	0.00525	CcSEcCtD
Cilazapril—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000164	0.00516	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000164	0.00515	CcSEcCtD
Cilazapril—Renal failure—Furosemide—dilated cardiomyopathy	0.000162	0.00511	CcSEcCtD
Cilazapril—Quinapril—ACE—dilated cardiomyopathy	0.000161	0.0974	CrCbGaD
Cilazapril—Lisinopril—ACE—dilated cardiomyopathy	0.000161	0.0974	CrCbGaD
Cilazapril—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000159	0.00502	CcSEcCtD
Cilazapril—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000159	0.00502	CcSEcCtD
Cilazapril—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000156	0.00491	CcSEcCtD
Cilazapril—Ramipril—ACE—dilated cardiomyopathy	0.000156	0.0944	CrCbGaD
Cilazapril—Trandolapril—ACE—dilated cardiomyopathy	0.000156	0.0944	CrCbGaD
Cilazapril—Face oedema—Lisinopril—dilated cardiomyopathy	0.000155	0.00488	CcSEcCtD
Cilazapril—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000154	0.00485	CcSEcCtD
Cilazapril—Urticaria—Spironolactone—dilated cardiomyopathy	0.000154	0.00484	CcSEcCtD
Cilazapril—Ataxia—Lisinopril—dilated cardiomyopathy	0.000151	0.00475	CcSEcCtD
Cilazapril—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000147	0.00462	CcSEcCtD
Cilazapril—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000146	0.0046	CcSEcCtD
Cilazapril—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000145	0.00457	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000145	0.00455	CcSEcCtD
Cilazapril—Visual impairment—Furosemide—dilated cardiomyopathy	0.000143	0.00449	CcSEcCtD
Cilazapril—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000142	0.00449	CcSEcCtD
Cilazapril—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00014	0.00441	CcSEcCtD
Cilazapril—Benazepril—ACE—dilated cardiomyopathy	0.00014	0.0848	CrCbGaD
Cilazapril—Tinnitus—Furosemide—dilated cardiomyopathy	0.000138	0.00435	CcSEcCtD
Cilazapril—Pruritus—Spironolactone—dilated cardiomyopathy	0.000137	0.00431	CcSEcCtD
Cilazapril—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000137	0.0043	CcSEcCtD
Cilazapril—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000136	0.00428	CcSEcCtD
Cilazapril—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000135	0.00426	CcSEcCtD
Cilazapril—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000135	0.00426	CcSEcCtD
Cilazapril—Angiopathy—Furosemide—dilated cardiomyopathy	0.000134	0.00423	CcSEcCtD
Cilazapril—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000134	0.00421	CcSEcCtD
Cilazapril—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000134	0.0042	CcSEcCtD
Cilazapril—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000132	0.00417	CcSEcCtD
Cilazapril—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000132	0.00417	CcSEcCtD
Cilazapril—Dysuria—Lisinopril—dilated cardiomyopathy	0.00013	0.00409	CcSEcCtD
Cilazapril—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00013	0.00409	CcSEcCtD
Cilazapril—Dizziness—Spironolactone—dilated cardiomyopathy	0.000128	0.00403	CcSEcCtD
Cilazapril—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000128	0.00403	CcSEcCtD
Cilazapril—Flatulence—Furosemide—dilated cardiomyopathy	0.000127	0.004	CcSEcCtD
Cilazapril—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000127	0.00399	CcSEcCtD
Cilazapril—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000126	0.00397	CcSEcCtD
Cilazapril—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000125	0.00394	CcSEcCtD
Cilazapril—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000124	0.0039	CcSEcCtD
Cilazapril—Vomiting—Spironolactone—dilated cardiomyopathy	0.000123	0.00387	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000123	0.00386	CcSEcCtD
Cilazapril—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000122	0.00384	CcSEcCtD
Cilazapril—Rash—Spironolactone—dilated cardiomyopathy	0.000122	0.00384	CcSEcCtD
Cilazapril—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000122	0.00384	CcSEcCtD
Cilazapril—Renal failure—Lisinopril—dilated cardiomyopathy	0.000122	0.00383	CcSEcCtD
Cilazapril—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000121	0.00382	CcSEcCtD
Cilazapril—Headache—Spironolactone—dilated cardiomyopathy	0.000121	0.00381	CcSEcCtD
Cilazapril—Anaemia—Furosemide—dilated cardiomyopathy	0.000119	0.00375	CcSEcCtD
Cilazapril—Enalapril—ACE—dilated cardiomyopathy	0.000118	0.0715	CrCbGaD
Cilazapril—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000117	0.00369	CcSEcCtD
Cilazapril—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000117	0.0206	CbGpPWpGaD
Cilazapril—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000117	0.00368	CcSEcCtD
Cilazapril—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000116	0.00366	CcSEcCtD
Cilazapril—Vertigo—Furosemide—dilated cardiomyopathy	0.000116	0.00365	CcSEcCtD
Cilazapril—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000116	0.00364	CcSEcCtD
Cilazapril—Leukopenia—Furosemide—dilated cardiomyopathy	0.000115	0.00363	CcSEcCtD
Cilazapril—Nausea—Spironolactone—dilated cardiomyopathy	0.000115	0.00362	CcSEcCtD
Cilazapril—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000113	0.00356	CcSEcCtD
Cilazapril—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000111	0.00351	CcSEcCtD
Cilazapril—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00011	0.00347	CcSEcCtD
Cilazapril—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00011	0.00345	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000109	0.00343	CcSEcCtD
Cilazapril—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000109	0.00343	CcSEcCtD
Cilazapril—Dry mouth—Furosemide—dilated cardiomyopathy	0.000107	0.00338	CcSEcCtD
Cilazapril—Confusional state—Furosemide—dilated cardiomyopathy	0.000106	0.00334	CcSEcCtD
Cilazapril—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000105	0.00331	CcSEcCtD
Cilazapril—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000104	0.00326	CcSEcCtD
Cilazapril—Shock—Furosemide—dilated cardiomyopathy	0.000104	0.00326	CcSEcCtD
Cilazapril—ABCB1—heart—dilated cardiomyopathy	0.000103	0.0172	CbGeAlD
Cilazapril—Flushing—Lisinopril—dilated cardiomyopathy	0.000103	0.00325	CcSEcCtD
Cilazapril—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000103	0.00324	CcSEcCtD
Cilazapril—Skin disorder—Furosemide—dilated cardiomyopathy	0.000102	0.00322	CcSEcCtD
Cilazapril—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000102	0.0032	CcSEcCtD
Cilazapril—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000101	0.00317	CcSEcCtD
Cilazapril—Anorexia—Furosemide—dilated cardiomyopathy	0.0001	0.00316	CcSEcCtD
Cilazapril—Chills—Lisinopril—dilated cardiomyopathy	9.97e-05	0.00314	CcSEcCtD
Cilazapril—Arrhythmia—Lisinopril—dilated cardiomyopathy	9.93e-05	0.00313	CcSEcCtD
Cilazapril—Hypotension—Furosemide—dilated cardiomyopathy	9.83e-05	0.0031	CcSEcCtD
Cilazapril—Alopecia—Lisinopril—dilated cardiomyopathy	9.82e-05	0.00309	CcSEcCtD
Cilazapril—Flatulence—Lisinopril—dilated cardiomyopathy	9.53e-05	0.003	CcSEcCtD
Cilazapril—Tension—Lisinopril—dilated cardiomyopathy	9.49e-05	0.00299	CcSEcCtD
Cilazapril—Dysgeusia—Lisinopril—dilated cardiomyopathy	9.47e-05	0.00298	CcSEcCtD
Cilazapril—Paraesthesia—Furosemide—dilated cardiomyopathy	9.45e-05	0.00297	CcSEcCtD
Cilazapril—ACE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	9.44e-05	0.0166	CbGpPWpGaD
Cilazapril—Nervousness—Lisinopril—dilated cardiomyopathy	9.39e-05	0.00296	CcSEcCtD
Cilazapril—Somnolence—Furosemide—dilated cardiomyopathy	9.35e-05	0.00294	CcSEcCtD
Cilazapril—Muscle spasms—Lisinopril—dilated cardiomyopathy	9.3e-05	0.00293	CcSEcCtD
Cilazapril—Decreased appetite—Furosemide—dilated cardiomyopathy	9.15e-05	0.00288	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	9.08e-05	0.00286	CcSEcCtD
Cilazapril—Fatigue—Furosemide—dilated cardiomyopathy	9.07e-05	0.00286	CcSEcCtD
Cilazapril—Tremor—Lisinopril—dilated cardiomyopathy	9.06e-05	0.00285	CcSEcCtD
Cilazapril—Pain—Furosemide—dilated cardiomyopathy	9e-05	0.00283	CcSEcCtD
Cilazapril—Constipation—Furosemide—dilated cardiomyopathy	9e-05	0.00283	CcSEcCtD
Cilazapril—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	8.97e-05	0.00283	CcSEcCtD
Cilazapril—Anaemia—Lisinopril—dilated cardiomyopathy	8.94e-05	0.00281	CcSEcCtD
Cilazapril—Angioedema—Lisinopril—dilated cardiomyopathy	8.84e-05	0.00278	CcSEcCtD
Cilazapril—Malaise—Lisinopril—dilated cardiomyopathy	8.72e-05	0.00275	CcSEcCtD
Cilazapril—Vertigo—Lisinopril—dilated cardiomyopathy	8.69e-05	0.00274	CcSEcCtD
Cilazapril—Syncope—Lisinopril—dilated cardiomyopathy	8.67e-05	0.00273	CcSEcCtD
Cilazapril—Feeling abnormal—Furosemide—dilated cardiomyopathy	8.67e-05	0.00273	CcSEcCtD
Cilazapril—Leukopenia—Lisinopril—dilated cardiomyopathy	8.66e-05	0.00273	CcSEcCtD
Cilazapril—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	8.6e-05	0.00271	CcSEcCtD
Cilazapril—Palpitations—Lisinopril—dilated cardiomyopathy	8.55e-05	0.00269	CcSEcCtD
Cilazapril—Loss of consciousness—Lisinopril—dilated cardiomyopathy	8.5e-05	0.00268	CcSEcCtD
Cilazapril—Cough—Lisinopril—dilated cardiomyopathy	8.44e-05	0.00266	CcSEcCtD
Cilazapril—Urticaria—Furosemide—dilated cardiomyopathy	8.36e-05	0.00263	CcSEcCtD
Cilazapril—Abdominal pain—Furosemide—dilated cardiomyopathy	8.32e-05	0.00262	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	8.27e-05	0.0145	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—TAZ—dilated cardiomyopathy	8.27e-05	0.0145	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	8.24e-05	0.0145	CbGpPWpGaD
Cilazapril—Myalgia—Lisinopril—dilated cardiomyopathy	8.24e-05	0.00259	CcSEcCtD
Cilazapril—Chest pain—Lisinopril—dilated cardiomyopathy	8.24e-05	0.00259	CcSEcCtD
Cilazapril—Arthralgia—Lisinopril—dilated cardiomyopathy	8.24e-05	0.00259	CcSEcCtD
Cilazapril—Anxiety—Lisinopril—dilated cardiomyopathy	8.21e-05	0.00258	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	8.18e-05	0.00257	CcSEcCtD
Cilazapril—Discomfort—Lisinopril—dilated cardiomyopathy	8.14e-05	0.00256	CcSEcCtD
Cilazapril—Dry mouth—Lisinopril—dilated cardiomyopathy	8.05e-05	0.00254	CcSEcCtD
Cilazapril—Confusional state—Lisinopril—dilated cardiomyopathy	7.96e-05	0.00251	CcSEcCtD
Cilazapril—Oedema—Lisinopril—dilated cardiomyopathy	7.89e-05	0.00249	CcSEcCtD
Cilazapril—Shock—Lisinopril—dilated cardiomyopathy	7.77e-05	0.00245	CcSEcCtD
Cilazapril—Hypersensitivity—Furosemide—dilated cardiomyopathy	7.75e-05	0.00244	CcSEcCtD
Cilazapril—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	7.73e-05	0.00243	CcSEcCtD
Cilazapril—Tachycardia—Lisinopril—dilated cardiomyopathy	7.7e-05	0.00243	CcSEcCtD
Cilazapril—Skin disorder—Lisinopril—dilated cardiomyopathy	7.67e-05	0.00241	CcSEcCtD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	7.65e-05	0.0135	CbGpPWpGaD
Cilazapril—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	7.63e-05	0.0024	CcSEcCtD
Cilazapril—Asthenia—Furosemide—dilated cardiomyopathy	7.55e-05	0.00238	CcSEcCtD
Cilazapril—Anorexia—Lisinopril—dilated cardiomyopathy	7.53e-05	0.00237	CcSEcCtD
Cilazapril—Pruritus—Furosemide—dilated cardiomyopathy	7.44e-05	0.00234	CcSEcCtD
Cilazapril—Hypotension—Lisinopril—dilated cardiomyopathy	7.38e-05	0.00232	CcSEcCtD
Cilazapril—Diarrhoea—Furosemide—dilated cardiomyopathy	7.2e-05	0.00227	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	7.19e-05	0.00226	CcSEcCtD
Cilazapril—Insomnia—Lisinopril—dilated cardiomyopathy	7.14e-05	0.00225	CcSEcCtD
Cilazapril—Paraesthesia—Lisinopril—dilated cardiomyopathy	7.09e-05	0.00223	CcSEcCtD
Cilazapril—Dyspnoea—Lisinopril—dilated cardiomyopathy	7.04e-05	0.00222	CcSEcCtD
Cilazapril—Somnolence—Lisinopril—dilated cardiomyopathy	7.02e-05	0.00221	CcSEcCtD
Cilazapril—Dizziness—Furosemide—dilated cardiomyopathy	6.96e-05	0.00219	CcSEcCtD
Cilazapril—Dyspepsia—Lisinopril—dilated cardiomyopathy	6.95e-05	0.00219	CcSEcCtD
Cilazapril—Decreased appetite—Lisinopril—dilated cardiomyopathy	6.86e-05	0.00216	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	6.82e-05	0.00215	CcSEcCtD
Cilazapril—Fatigue—Lisinopril—dilated cardiomyopathy	6.81e-05	0.00214	CcSEcCtD
Cilazapril—Pain—Lisinopril—dilated cardiomyopathy	6.75e-05	0.00213	CcSEcCtD
Cilazapril—Constipation—Lisinopril—dilated cardiomyopathy	6.75e-05	0.00213	CcSEcCtD
Cilazapril—Vomiting—Furosemide—dilated cardiomyopathy	6.69e-05	0.00211	CcSEcCtD
Cilazapril—Rash—Furosemide—dilated cardiomyopathy	6.63e-05	0.00209	CcSEcCtD
Cilazapril—Dermatitis—Furosemide—dilated cardiomyopathy	6.63e-05	0.00209	CcSEcCtD
Cilazapril—Headache—Furosemide—dilated cardiomyopathy	6.59e-05	0.00208	CcSEcCtD
Cilazapril—Feeling abnormal—Lisinopril—dilated cardiomyopathy	6.51e-05	0.00205	CcSEcCtD
Cilazapril—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	6.46e-05	0.00203	CcSEcCtD
Cilazapril—Urticaria—Lisinopril—dilated cardiomyopathy	6.27e-05	0.00197	CcSEcCtD
Cilazapril—Nausea—Furosemide—dilated cardiomyopathy	6.25e-05	0.00197	CcSEcCtD
Cilazapril—Abdominal pain—Lisinopril—dilated cardiomyopathy	6.24e-05	0.00196	CcSEcCtD
Cilazapril—Hypersensitivity—Lisinopril—dilated cardiomyopathy	5.82e-05	0.00183	CcSEcCtD
Cilazapril—Asthenia—Lisinopril—dilated cardiomyopathy	5.66e-05	0.00178	CcSEcCtD
Cilazapril—Pruritus—Lisinopril—dilated cardiomyopathy	5.59e-05	0.00176	CcSEcCtD
Cilazapril—Diarrhoea—Lisinopril—dilated cardiomyopathy	5.4e-05	0.0017	CcSEcCtD
Cilazapril—Dizziness—Lisinopril—dilated cardiomyopathy	5.22e-05	0.00164	CcSEcCtD
Cilazapril—Vomiting—Lisinopril—dilated cardiomyopathy	5.02e-05	0.00158	CcSEcCtD
Cilazapril—Rash—Lisinopril—dilated cardiomyopathy	4.98e-05	0.00157	CcSEcCtD
Cilazapril—Dermatitis—Lisinopril—dilated cardiomyopathy	4.97e-05	0.00157	CcSEcCtD
Cilazapril—Headache—Lisinopril—dilated cardiomyopathy	4.95e-05	0.00156	CcSEcCtD
Cilazapril—Nausea—Lisinopril—dilated cardiomyopathy	4.69e-05	0.00148	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.31e-05	0.00757	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.19e-05	0.00737	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.19e-05	0.00737	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4e-05	0.00703	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.89e-05	0.00685	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.89e-05	0.00684	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.89e-05	0.00684	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.61e-05	0.00636	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	3.31e-05	0.00582	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—LMNA—dilated cardiomyopathy	3.26e-05	0.00573	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	2.79e-05	0.0049	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	2.33e-05	0.0041	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	2.17e-05	0.00382	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	2.09e-05	0.00368	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—AGT—dilated cardiomyopathy	1.78e-05	0.00313	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.35e-05	0.00238	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.31e-05	0.00231	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.31e-05	0.00231	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.22e-05	0.00215	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.07e-05	0.00188	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.03e-05	0.00182	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.01e-05	0.00178	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	8.88e-06	0.00156	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	8.88e-06	0.00156	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.5e-06	0.00149	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	8.35e-06	0.00147	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.88e-06	0.00139	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	7.55e-06	0.00133	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.71e-06	0.00118	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.6e-06	0.00081	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.38e-06	0.000771	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.67e-06	0.000469	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.05e-06	0.000361	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2e-06	0.000351	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.8e-06	0.000316	CbGpPWpGaD
